Targeting the microbiome in Crohn's disease

被引：4
作者：
Borody, Thomas J. [1 ]
Dolai, Sibasish [1 ]
Gunaratne, Anoja W. [1 ]
Clancy, Robert L. [1 ]
机构：
[1] Ctr Digest Dis, Res Dept, Five Dock, Australia
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2022年 / 18卷 / 09期
关键词：
Anti-mycobacterial therapy; Crohn's disease; Crohn's strictures; dysbiosis; fecal microbiota transplantation; gut microbiome; inflammatory bowel disease; Mycobacterium avium subspecies paratuberculosis (MAP); profound remission; AVIUM SUBSPECIES PARATUBERCULOSIS; INFLAMMATORY-BOWEL-DISEASE; MACROLIDE-CLOFAZIMINE COMBINATION; ANTIBIOTIC-THERAPY; MYCOBACTERIUM-PARATUBERCULOSIS; RIFABUTIN; PATHOGENESIS; MAP; CD;
D O I：
10.1080/1744666X.2022.2093186
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：873 / 877
页数：5
相关论文
共 50 条
  • [21] Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease
    Lv, Yao
    Zhen, Changjun
    Liu, Ana
    Hu, Yudie
    Yang, Gan
    Xu, Cuifang
    Lou, Yue
    Cheng, Qi
    Luo, Youyou
    Yu, Jindan
    Fang, Youhong
    Zhao, Hong
    Peng, Kerong
    Yu, Yu
    Lou, Jingan
    Chen, Jie
    Ni, Yan
    MSYSTEMS, 2024, 9 (09)
  • [22] Unraveling the blood microbiome: novel insights into inflammasome responses in Crohn's disease
    Kirkik, Duygu
    Kalkanli Tas, Sevgi
    Tanoglu, Alpaslan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (08) : 975 - 984
  • [23] The pathogenesis of Crohn's disease
    Okabe, N
    DIGESTION, 2001, 63 : 52 - 59
  • [24] Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn's disease: an overview and update
    Honap, Sailish
    Johnston, Emma
    Agrawal, Gaurav
    Al-Hakim, Bahij
    Hermon-Taylor, John
    Sanderson, Jeremy
    FRONTLINE GASTROENTEROLOGY, 2021, 12 (05) : 397 - 403
  • [25] Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis
    Saskia Thomas
    Daniel C. Baumgart
    Inflammopharmacology, 2012, 20 (1) : 1 - 18
  • [26] Targeting opioid signaling in Crohn's disease: new therapeutic pathways
    Zagon, Ian S.
    McLaughlin, Patricia J.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (05) : 555 - 558
  • [27] Targeting the gut layers in Crohn's disease: mucosal or transmural healing?
    Zacharopoulou, Eirini
    Craviotto, Vincenzo
    Fiorino, Gionata
    Furfaro, Federica
    Zilli, Alessandra
    Gilardi, Daniela
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Allocca, Mariangela
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (09) : 775 - 787
  • [28] The Common and Unique Pattern of Microbiome Profiles among Saliva, Tissue, and Stool Samples in Patients with Crohn's Disease
    Shin, Seung Yong
    Kim, Sounkou
    Choi, Ji Won
    Kang, Sang-Bum
    Kim, Tae Oh
    Seo, Geom Seog
    Cha, Jae Myung
    Chun, Jaeyoung
    Jung, Yunho
    Im, Jong Pil
    Bang, Ki Bae
    Choi, Chang Hwan
    Park, Soo-Kyung
    Park, Dong Il
    MICROORGANISMS, 2022, 10 (07)
  • [29] Exploring gut microbiota as a novel therapeutic target in Crohn's disease: Insights and emerging strategies
    Qiao, Tong
    Wen, Xian-Hui
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (02)
  • [30] The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review
    MacLellan, Amber
    Connors, Jessica
    Grant, Shannan
    Cahill, Leah
    Langille, Morgan G. I.
    Van Limbergen, Johan
    NUTRIENTS, 2017, 9 (05):
12345